Navigation Links
In a Down Economy, Women's Health Company Announces Growth
Date:11/13/2008

WAYNE, Pa., Nov. 13 /PRNewswire/ -- At a time when industry retrenchment, lay-offs and even bail outs dominate the news, a specialty pharmaceutical company located outside Philadelphia is experiencing growth. This week, FemmePharma Global Healthcare, Inc announces the establishment of a new division, FemmePharma Mental Healthcare, Central Nervous System, that will focus on central nervous system (CNS) disorders in women.

"We are energized to expand our commitment in women's health even at a time when the pharmaceutical industry is retreating in this area," says FemmePharma's President and CEO Gerianne Tringali DiPiano. "For FemmePharma, these are times which provide a wealth of opportunities in women's health."

Since its establishment in 1996, FemmePharma has focused on women's gynecological health issues, including urinary incontinence and fibrocystic breast disease. With its expansion into CNS, that focus is growing to develop treatments particularly for depression (including postpartum depression), anxiety disorders, eating disorders and neuropathic pain specific to women.

"We know that women respond differently than men to medications for depression," Tringali DiPiano says, referring to a study published in 2006 in the Journal of Affective Disorders. "And this is just one example. Understanding and developing treatments that respond to women's unique health challenges is FemmePharma's mission so our expansion into CNS disorders in women represents a natural progression," Tringali DiPiano says.

While FemmePharma continues to invest and grow, the pharmaceutical industry in general is withdrawing. In April of this year, a Wall Street Journal website estimated that as many as 25,000 pharmaceutical jobs were expected to be eliminated in 2008. And in October, Wyeth announced that it would eliminate discovery work in women's health while reducing its therapeutic areas from 14 to six.

Tringali DiPiano says this represents a concern for her personally while providing an exciting opportunity for her company.

"The gap in developing treatments unique to women is widening even though there are significant unmet needs," Tringali DiPiano says. "Without question our expansion into CNS is an indication of our continued growth and commitment to women and their unique health needs."

The women's health sector represents an estimated $116 billion market by the year 2010, according to a report by Research and Markets.com.


'/>"/>
SOURCE FemmePharma Global Healthcare, Inc
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Economy, Health Care, and Gas Prices Top Issues for Women Business Owners
2. Ban on betting would boost ailing economy, gambling critic says
3. Despite U.S. economy, more Americans seeking cosmetic surgery overseas
4. Womenshealthchannel Enhancements Support Pregnant Teens
5. Penn study finds pro-death proteins required to regulate healthy immune function
6. UCLA researchers identify markers that may predict diabetes in still-healthy people
7. Air pollution linked to cardiovascular risk indices in healthy young adults
8. More proof needed of safety and quality of electronic personal health records
9. Health care incentive model offers collaborative approach
10. Loneliness is bad for your health
11. Mailman School of Public Health study examines link between racial discrimination and substance use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental ... sedation dentistry in Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team ... of treatments. One or more sedation methods may be recommended based on the severity ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... “Homeostasis: The ... experience learning to live with Bipolar 1. Donald Rodriguez takes readers on a rollercoaster ... Alaska in the dead of winter and to a dark place where Donald considers ...
(Date:5/22/2017)... IL (PRWEB) , ... May 22, 2017 , ... ... is part of a larger group investing in InsightRX, an early stage company ... patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted ...
(Date:5/21/2017)... ... May 20, 2017 , ... Pixel Film Studios presents ... use in Final Cut Pro X. The business-oriented elements and dignified animations are ... ProParagraph Corporate will deliver a professional and distinguished look to any multi-line text ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 ... a wide range of knives and swords, from functional to fantasy. United Cutlery has ... with sleek, modern designs that defy tradition. , Offering a range of weapons and ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its commitment ... of directors for the Pharmaceutical Research and Manufacturers ... membership. Biopharmaceutical companies will now have to meet ... to be eligible to join PhRMA. ... board is sending a clear message that being ...
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, ... provides technology solutions to improve the clinical effectiveness ... results for the first quarter ended March 31, ... products enable our customers to identify when preventive ... intervene before events like heart attacks or strokes ...
Breaking Medicine Technology: